Drug Pipeline

We have a developing pipeline of drugs for out-licensing to our partners, in order to rapidly bring them to the clinic for unmet clinical need including:

RP 1486. A small molecule with a novel mitochondrial target for use in lung cancer .

RP 1486 is currently in pre-clinical trials and will be available shortly for clinical trials.